208 related articles for article (PubMed ID: 2971756)
1. Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase.
Letarte M; Vera S; Tran R; Addis JB; Onizuka RJ; Quackenbush EJ; Jongeneel CV; McInnes RR
J Exp Med; 1988 Oct; 168(4):1247-53. PubMed ID: 2971756
[TBL] [Abstract][Full Text] [Related]
2. The common acute lymphoblastic leukemia antigen (neutral endopeptidase-3.4.24.11) gene is located on human chromosome 3.
Tran-Paterson R; Willard HF; Letarte M
Cancer Genet Cytogenet; 1989 Oct; 42(1):129-34. PubMed ID: 2529024
[TBL] [Abstract][Full Text] [Related]
3. Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5' untranslated regions.
D'Adamio L; Shipp MA; Masteller EL; Reinherz EL
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7103-7. PubMed ID: 2528730
[TBL] [Abstract][Full Text] [Related]
4. Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 ("enkephalinase"): direct evidence by cDNA transfection analysis.
Shipp MA; Vijayaraghavan J; Schmidt EV; Masteller EL; D'Adamio L; Hersh LB; Reinherz EL
Proc Natl Acad Sci U S A; 1989 Jan; 86(1):297-301. PubMed ID: 2521388
[TBL] [Abstract][Full Text] [Related]
5. Human glioma cell lines expressing the common acute lymphoblastic leukemia antigen (cALLa) have neutral endopeptidase activity.
Monod L; Diserens AC; Jongeneel CV; Carrel S; Ronco P; Verroust P; de Tribolet N
Int J Cancer; 1989 Nov; 44(5):948-51. PubMed ID: 2531122
[TBL] [Abstract][Full Text] [Related]
6. Common acute lymphoblastic leukemia antigen expressed on leukemia and melanoma cell lines has neutral endopeptidase activity.
Jongeneel CV; Quackenbush EJ; Ronco P; Verroust P; Carrel S; Letarte M
J Clin Invest; 1989 Feb; 83(2):713-7. PubMed ID: 2521492
[TBL] [Abstract][Full Text] [Related]
7. Murine common acute lymphoblastic leukemia antigen (CD10 neutral endopeptidase 24.11). Molecular characterization, chromosomal localization, and modeling of the active site.
Chen CY; Salles G; Seldin MF; Kister AE; Reinherz EL; Shipp MA
J Immunol; 1992 May; 148(9):2817-25. PubMed ID: 1374101
[TBL] [Abstract][Full Text] [Related]
8. Exon 16 del: a novel form of human neutral endopeptidase (CALLA).
Iijima H; Gerard NP; Squassoni C; Ewig J; Face D; Drazen JM; Kim YA; Shriver B; Hersh LB; Gerard C
Am J Physiol; 1992 Jun; 262(6 Pt 1):L725-9. PubMed ID: 1535484
[TBL] [Abstract][Full Text] [Related]
9. Comparative levels of CALLA/neutral endopeptidase on normal granulocytes, leukemic cells, and transfected COS-1 cells.
Tran-Paterson R; Boileau G; Giguère V; Letarte M
Blood; 1990 Aug; 76(4):775-82. PubMed ID: 2166607
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein.
Shipp MA; Richardson NE; Sayre PH; Brown NR; Masteller EL; Clayton LK; Ritz J; Reinherz EL
Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4819-23. PubMed ID: 2968607
[TBL] [Abstract][Full Text] [Related]
11. CD10 and CD44 genes of leukemic cells and malignant cell lines show no evidence of transformation-related alterations.
Kee BL; Dadi HK; Tran-Paterson R; Quackenbush EJ; Andrulis IL; Letarte M
J Cell Physiol; 1991 Sep; 148(3):414-20. PubMed ID: 1833412
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of enkephalinase (EC 3.4.24.11) activity on various leukemic cells expressing the common acute lymphocytic leukemia antigen (CALLA).
Arock M; Gros C; Devillier P; Guillosson JJ; Schwartz JC
FEBS Lett; 1989 May; 248(1-2):123-6. PubMed ID: 2524403
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas.
Dragović T; Deddish PA; Tan F; Weber G; Erdös EG
Lab Invest; 1994 Jan; 70(1):107-13. PubMed ID: 8302012
[TBL] [Abstract][Full Text] [Related]
14. The non immunogenicity of CALLA in leukemic children.
Komada Y; Yamamoto H; Azuma E; Tanaka S; Kamiya H; Sakurai M
Biomed Pharmacother; 1988; 42(10):669-73. PubMed ID: 2976604
[TBL] [Abstract][Full Text] [Related]
15. [Characterization of murine monoclonal antibodies against the common acute leukemia antigen (CALLA)].
Seifert M; Eichler W; Fiebig H
Allerg Immunol (Leipz); 1990; 36(4):267-76. PubMed ID: 2151502
[TBL] [Abstract][Full Text] [Related]
16. Neutral endopeptidase 24.11 and angiotensin converting enzyme like activity in CALLA positive and CALLA negative lymphoid cells.
Beaumont A; Brouet JC; Roques BP
Biochem Biophys Res Commun; 1989 May; 160(3):1323-9. PubMed ID: 2543397
[TBL] [Abstract][Full Text] [Related]
17. The common acute lymphoblastic leukemia antigen gene maps to chromosomal region 3 (q21-q27).
Barker PE; Shipp MA; D'Adamio L; Masteller EL; Reinherz EL
J Immunol; 1989 Jan; 142(1):283-7. PubMed ID: 2521237
[TBL] [Abstract][Full Text] [Related]
18. Expression of cALLa/NEP on gliomas: a possible marker of malignancy.
Monod L; Hamou MF; Ronco P; Verroust P; de Tribolet N
Acta Neurochir (Wien); 1992; 114(1-2):3-7. PubMed ID: 1532880
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and primary structure of Kell blood group protein.
Lee S; Zambas ED; Marsh WL; Redman CM
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6353-7. PubMed ID: 1712490
[TBL] [Abstract][Full Text] [Related]
20. Modulation of CALLA (CD10) antigen on cultured ALL (REH) cells: effect of various modulators.
Chorváth B; Sedlák J; Duraj J; Plesková I; Dubovský P; Augustinová M; Doxiadis I; Grosse-Wilde H
Neoplasma; 1990; 37(6):609-18. PubMed ID: 2148811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]